doi.org/10.1016/j.cell.2020.02.052

Original paper

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann

,

Hannah Kleine-Weber

,

..., Stefan Pöhlmann

Cell42.50

Volume: 181, Issue: 2, Pages: 271 - 280.e8

Published: Apr 16, 2020

Paper Fields

Paper Details

Title

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

DOI

doi.org/10.1016/j.cell.2020.02.052

Published Date

Apr 16, 2020

Journal

Volume

181

Issue

2

Pages

271 - 280.e8

Notes

History